ADMA Biologics
ADMA
ADMA
90 hedge funds and large institutions have $67.7M invested in ADMA Biologics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 32 closing their positions.
Holders
90
Holders Change
-15
Holders Change %
-14.29%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
20
Reduced
35
Closed
32
Calls
$712K
Puts
$3.49M
Net Calls
-$2.78M
Net Calls Change
-$513K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$8.98M |
| 2 |
2
Millennium Management
New York
|
$1.6M |
| 3 |
CC
3
Clearline Capital
New York
|
$1.48M |
| 4 |
GCP
4
GSA Capital Partners
London,
United Kingdom
|
$1.38M |
| 5 |
E
5
Ergoteles
New York
|
$479K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$3.48M |
| 2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$9.45M |
| 3 |
MS
3
Maven Securities
St Helier,
Jersey
|
$0 |
| 4 |
4
State Street
Boston,
Massachusetts
|
$655K |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$474K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Fidelity Investments
Boston,
Massachusetts
| $0 | 1 | +1 | New |
|